id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2007-D-0369-2421,FDA,FDA-2007-D-0369,PSG_208564 Draft Guidance on Estradiol,Other,Guidance,2025-12-16T05:00:00Z,2025,12,2025-12-16T05:00:00Z,,2025-12-16T20:30:49Z,,1,0,09000064b90dccd3
FDA-2007-D-0369-2420,FDA,FDA-2007-D-0369,PSG_020908 Draft Guidance on Estradiol,Other,Guidance,2025-12-16T05:00:00Z,2025,12,2025-12-16T05:00:00Z,,2025-12-16T20:27:46Z,,1,0,09000064b90dccd1
FDA-2007-D-0369-2419,FDA,FDA-2007-D-0369,Product-Specific Guidance on Estradiol; Draft Guidance for Industry; Availability,Notice,Notice of Availability,2025-12-08T05:00:00Z,2025,12,2025-12-08T05:00:00Z,,2025-12-09T00:20:26Z,2025-22249,0,0,09000064b90b585d
FDA-2007-D-0369-2338,FDA,FDA-2007-D-0369,PSG_216540 - Draft Guidance on Acoramidis Hydrochloride,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:42:47Z,,1,0,09000064b90ae511
FDA-2007-D-0369-2409,FDA,FDA-2007-D-0369,PSG_215272 - Draft Guidance on Tapinarof,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T23:12:18Z,,1,0,09000064b90aee6c
FDA-2007-D-0369-2392,FDA,FDA-2007-D-0369,PSG_215014 - Draft Guidance on Pegcetacoplan,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T23:10:17Z,,1,0,09000064b90aee4a
FDA-2007-D-0369-2407,FDA,FDA-2007-D-0369,PSG_219209 - Draft Guidance on Suzetrigine,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T23:12:08Z,,1,0,09000064b90aee68
FDA-2007-D-0369-2402,FDA,FDA-2007-D-0369,PSG_218944 - Draft Guidance on Revumenib Citrate,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T23:11:43Z,,1,0,09000064b90aee5e
FDA-2007-D-0369-2388,FDA,FDA-2007-D-0369,PSG_022000 - Draft Guidance on Mesalamine,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T23:09:56Z,,1,0,09000064b90aee42
FDA-2007-D-0369-2360,FDA,FDA-2007-D-0369,PSG_020062 - Draft Guidance on Diltiazem Hydrochloride,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:48:31Z,,1,0,09000064b90aee05
FDA-2007-D-0369-2382,FDA,FDA-2007-D-0369,PSG_211913 - Draft Guidance on Isotretinoin,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:56:51Z,,1,0,09000064b90aee34
FDA-2007-D-0369-2351,FDA,FDA-2007-D-0369,PSG_022012 - Draft Guidance on Carvedilol Phosphate,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:46:04Z,,1,0,09000064b90ae582
FDA-2007-D-0369-2366,FDA,FDA-2007-D-0369,PSG_214697 - Draft Guidance on Epinephrine,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:50:08Z,,1,0,09000064b90aee11
FDA-2007-D-0369-2374,FDA,FDA-2007-D-0369,PSG_218230 - Draft Guidance on Gepotidacin Mesylate,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:55:39Z,,1,0,09000064b90aee21
FDA-2007-D-0369-2369,FDA,FDA-2007-D-0369,PSG_210132 - Draft Guidance on Estradiol; Progesterone,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:51:18Z,,1,0,09000064b90aee17
FDA-2007-D-0369-2377,FDA,FDA-2007-D-0369,PSG_219141 - Draft Guidance on Hydrochlorothiazide,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:56:10Z,,1,0,09000064b90aee27
FDA-2007-D-0369-2379,FDA,FDA-2007-D-0369,PSG_214581 - Draft Guidance on Hydroxychloroquine Sulfate,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:56:28Z,,1,0,09000064b90aee2b
FDA-2007-D-0369-2344,FDA,FDA-2007-D-0369,PSG_208772 - Draft Guidance on Brigatinib,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:44:15Z,,1,0,09000064b90ae576
FDA-2007-D-0369-2393,FDA,FDA-2007-D-0369,PSG_214511 - Draft Guidance on Pegulicianine Acetate,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T23:10:23Z,,1,0,09000064b90aee4c
FDA-2007-D-0369-2411,FDA,FDA-2007-D-0369,PSG_021318 - Draft Guidance on Teriparatide,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T23:12:28Z,,1,0,09000064b90aee70
FDA-2007-D-0369-2412,FDA,FDA-2007-D-0369,PSG_208088 - Draft Guidance on Testosterone Undecanoate,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T23:12:33Z,,1,0,09000064b90aee72
FDA-2007-D-0369-2401,FDA,FDA-2007-D-0369,PSG_009829 - Draft Guidance on Pyridostigmine Bromide,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T23:11:35Z,,1,0,09000064b90aee5c
FDA-2007-D-0369-2404,FDA,FDA-2007-D-0369,PSG_218160 - Draft Guidance on Selpercatinib,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T23:11:53Z,,1,0,09000064b90aee62
FDA-2007-D-0369-2383,FDA,FDA-2007-D-0369,PSG_208462 - Draft Guidance on Ixazomib Citrate,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:56:59Z,,1,0,09000064b90aee38
FDA-2007-D-0369-2367,FDA,FDA-2007-D-0369,PSG_021323-ODT - Draft Guidance on Escitalopram Oxalate,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:50:24Z,,1,0,09000064b90aee13
FDA-2007-D-0369-2385,FDA,FDA-2007-D-0369,PSG_219132 - Draft Guidance on Levacetylleucine,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:57:14Z,,1,0,09000064b90aee3c
FDA-2007-D-0369-2368,FDA,FDA-2007-D-0369,PSG_214846 - Draft Guidance on Estradiol; Norethindrone Acetate; Relugolix,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:50:41Z,,1,0,09000064b90aee15
FDA-2007-D-0369-2353,FDA,FDA-2007-D-0369,PSG_212839 - Draft Guidance on Cenobamate,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:46:32Z,,1,0,09000064b90ae586
FDA-2007-D-0369-2343,FDA,FDA-2007-D-0369,PSG_215064 - Draft Guidance on Birch Triterpenes,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2026-02-07T13:12:43Z,,1,0,09000064b90ae574
FDA-2007-D-0369-2375,FDA,FDA-2007-D-0369,PSG_212097 - Draft Guidance on Glucagon,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:55:54Z,,1,0,09000064b90aee23
FDA-2007-D-0369-2362,FDA,FDA-2007-D-0369,PSG_218860 - Draft Guidance on Elafibranor,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:49:00Z,,1,0,09000064b90aee09
FDA-2007-D-0369-2365,FDA,FDA-2007-D-0369,PSG_019430 - Draft Guidance on Epinephrine,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:49:53Z,,1,0,09000064b90aee0f
FDA-2007-D-0369-2381,FDA,FDA-2007-D-0369,PSG_216017 - Draft Guidance on Iomeprol,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:56:43Z,,1,0,09000064b90aee2f
FDA-2007-D-0369-2370,FDA,FDA-2007-D-0369,PSG_018922-Tab - Draft Guidance on Etodolac,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:54:41Z,,1,0,09000064b90aee19
FDA-2007-D-0369-2364,FDA,FDA-2007-D-0369,PSG_218171 - Draft Guidance on Ensartinib Hydrochloride,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:49:32Z,,1,0,09000064b90aee0d
FDA-2007-D-0369-2356,FDA,FDA-2007-D-0369,PSG_202806 - Draft Guidance on Dabrafenib Mesylate,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:47:14Z,,1,0,09000064b90ae58c
FDA-2007-D-0369-2339,FDA,FDA-2007-D-0369,PSG_214056 - Draft Guidance on Apomorphine Hydrochloride,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:43:17Z,,1,0,09000064b90ae56c
FDA-2007-D-0369-2398,FDA,FDA-2007-D-0369,PSG_009170-ODT - Draft Guidance on Primidone,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T23:11:00Z,,1,0,09000064b90aee56
FDA-2007-D-0369-2399,FDA,FDA-2007-D-0369,PSG_015193 - Draft Guidance on Pyridostigmine Bromide,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T23:11:06Z,,1,0,09000064b90aee58
FDA-2007-D-0369-2414,FDA,FDA-2007-D-0369,PSG_214759 - Draft Guidance on Treosulfan,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T23:12:43Z,,1,0,09000064b90aee76
FDA-2007-D-0369-2397,FDA,FDA-2007-D-0369,PSG_017469 - Draft Guidance on Prednisolone Acetate,Other,Letter(s),2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T23:10:44Z,,1,0,09000064b90aee54
FDA-2007-D-0369-2390,FDA,FDA-2007-D-0369,PSG_021636 - Draft Guidance on Omeprazole; Sodium Bicarbonate,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T23:10:07Z,,1,0,09000064b90aee46
FDA-2007-D-0369-2417,FDA,FDA-2007-D-0369,PSG_022103 - Draft Guidance on Trospium Chloride,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T23:13:00Z,,1,0,09000064b90aee7c
FDA-2007-D-0369-2405,FDA,FDA-2007-D-0369,PSG_215256 - Draft Guidance on Semaglutide,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T23:11:58Z,,1,0,09000064b90aee64
FDA-2007-D-0369-2406,FDA,FDA-2007-D-0369,PSG_021938 - Draft Guidance on Sunitinib Malate,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T23:12:03Z,,1,0,09000064b90aee66
FDA-2007-D-0369-2408,FDA,FDA-2007-D-0369,PSG_217439 - Draft Guidance on Talazoparib Tosylate,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T23:12:13Z,,1,0,09000064b90aee6a
FDA-2007-D-0369-2413,FDA,FDA-2007-D-0369,PSG_215866 - Draft Guidance on Tirzepatide,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T23:12:38Z,,1,0,09000064b90aee74
FDA-2007-D-0369-2391,FDA,FDA-2007-D-0369,PSG_217171 - Draft Guidance on Pegcetacoplan,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T23:10:12Z,,1,0,09000064b90aee48
FDA-2007-D-0369-2400,FDA,FDA-2007-D-0369,PSG_217604 - Draft Guidance on Pyridostigmine Bromide,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T23:11:19Z,,1,0,09000064b90aee5a
FDA-2007-D-0369-2389,FDA,FDA-2007-D-0369,PSG_213593 - Draft Guidance on Omeprazole; Sodium Bicarbonate,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T23:10:02Z,,1,0,09000064b90aee44
FDA-2007-D-0369-2387,FDA,FDA-2007-D-0369,PSG_206321 - Draft Guidance on Liraglutide,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T23:09:51Z,,1,0,09000064b90aee40
FDA-2007-D-0369-2350,FDA,FDA-2007-D-0369,PSG_022556 - Draft Guidance on Carbinoxamine Maleate,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:45:51Z,,1,0,09000064b90ae580
FDA-2007-D-0369-2371,FDA,FDA-2007-D-0369,PSG_212102 - Draft Guidance on Fenfluramine Hydrochloride,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:54:52Z,,1,0,09000064b90aee1b
FDA-2007-D-0369-2361,FDA,FDA-2007-D-0369,PSG_218711 - Draft Guidance on Docetaxel,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:48:45Z,,1,0,09000064b90aee07
FDA-2007-D-0369-2376,FDA,FDA-2007-D-0369,PSG_210134 - Draft Guidance on Glucagon,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:56:03Z,,1,0,09000064b90aee25
FDA-2007-D-0369-2357,FDA,FDA-2007-D-0369,PSG_214231 - Draft Guidance on Dasiglucagon Hydrochloride,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:47:34Z,,1,0,09000064b90ae58e
FDA-2007-D-0369-2340,FDA,FDA-2007-D-0369,PSG_214927 - Draft Guidance on Arimoclomol Citrate,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:43:26Z,,1,0,09000064b90ae56e
FDA-2007-D-0369-2345,FDA,FDA-2007-D-0369,PSG_215935 - Draft Guidance on Budesonide,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:44:28Z,,1,0,09000064b90ae578
FDA-2007-D-0369-2418,FDA,FDA-2007-D-0369,PSG_214938 - Draft Guidance on Vosoritide,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-08T10:00:23Z,,1,0,09000064b90aee7e
FDA-2007-D-0369-2359,FDA,FDA-2007-D-0369,PSG_218730 - Draft Guidance on Deutivacaftor; Tezacaftor; Vanzacaftor Calcium,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:48:17Z,,1,0,09000064b90aee03
FDA-2007-D-0369-2373,FDA,FDA-2007-D-0369,PSG_020121 - Draft Guidance on Fluticasone Propionate,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:55:30Z,,1,0,09000064b90aee1f
FDA-2007-D-0369-2358,FDA,FDA-2007-D-0369,PSG_017922 - Draft Guidance on Desmopressin Acetate,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:47:49Z,,1,0,09000064b90ae590
FDA-2007-D-0369-2384,FDA,FDA-2007-D-0369,PSG_205388 - Draft Guidance on Ketorolac Tromethamine; Phenylephrine Hydrochloride,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:57:07Z,,1,0,09000064b90aee3a
FDA-2007-D-0369-2352,FDA,FDA-2007-D-0369,PSG_216165 - Draft Guidance on Cefepime Hydrochloride; Enmetazobactam,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:46:18Z,,1,0,09000064b90ae584
FDA-2007-D-0369-2380,FDA,FDA-2007-D-0369,PSG_216016 - Draft Guidance on Iomeprol,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:56:36Z,,1,0,09000064b90aee2d
FDA-2007-D-0369-2363,FDA,FDA-2007-D-0369,"PSG_217660 - Draft Guidance on Elexacaftor, Ivacaftor, Tezacaftor; Ivacaftor",Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:49:16Z,,1,0,09000064b90aee0b
FDA-2007-D-0369-2372,FDA,FDA-2007-D-0369,PSG_215168 - Draft Guidance on Flurpiridaz F-18,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:55:21Z,,1,0,09000064b90aee1d
FDA-2007-D-0369-2342,FDA,FDA-2007-D-0369,PSG_207924 - Draft Guidance on Baricitinib,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:43:47Z,,1,0,09000064b90ae572
FDA-2007-D-0369-2347,FDA,FDA-2007-D-0369,PSG_215430 - Draft Guidance on Bupropion Hydrochloride; Dextromethorphan Hydrobromide,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:44:56Z,,1,0,09000064b90ae57c
FDA-2007-D-0369-2341,FDA,FDA-2007-D-0369,PSG_017851 - Draft Guidance on Baclofen,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:43:37Z,,1,0,09000064b90ae570
FDA-2007-D-0369-2410,FDA,FDA-2007-D-0369,PSG_213931 - Draft Guidance on Tenapanor Hydrochloride,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T23:12:23Z,,1,0,09000064b90aee6e
FDA-2007-D-0369-2395,FDA,FDA-2007-D-0369,PSG_214770 - Draft Guidance on Poscaconazole,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T23:10:33Z,,1,0,09000064b90aee50
FDA-2007-D-0369-2403,FDA,FDA-2007-D-0369,PSG_217242 - Draft Guidance on Roflumilast,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-23T10:00:12Z,,1,0,09000064b90aee60
FDA-2007-D-0369-2415,FDA,FDA-2007-D-0369,PSG_214324 - Draft Guidance on Treprostinil,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T23:12:48Z,,1,0,09000064b90aee78
FDA-2007-D-0369-2386,FDA,FDA-2007-D-0369,PSG_022341 - Draft Guidance on Liraglutide,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T23:09:46Z,,1,0,09000064b90aee3e
FDA-2007-D-0369-2396,FDA,FDA-2007-D-0369,PSG_019561 - Draft Guidance on Potassium chloride,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T23:10:38Z,,1,0,09000064b90aee52
FDA-2007-D-0369-2416,FDA,FDA-2007-D-0369,PSG_017340 - Draft Guidance on Tretinoin,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T23:12:53Z,,1,0,09000064b90aee7a
FDA-2007-D-0369-2394,FDA,FDA-2007-D-0369,PSG_216483 - Draft Guidance on Pivmecillinam Hydrochloride,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T23:10:28Z,,1,0,09000064b90aee4e
FDA-2007-D-0369-2349,FDA,FDA-2007-D-0369,PSG_017769 - Draft Guidance on Calcitonin Salmon,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:45:35Z,,1,0,09000064b90af592
FDA-2007-D-0369-2378,FDA,FDA-2007-D-0369,PSG_018303 - Draft Guidance on Hydrochlorothiazide; Metoprolol Tartrate,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:56:19Z,,1,0,09000064b90aee29
FDA-2007-D-0369-2354,FDA,FDA-2007-D-0369,PSG_218808 - Draft Guidance on Crinecerfont,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:46:46Z,,1,0,09000064b90ae588
FDA-2007-D-0369-2348,FDA,FDA-2007-D-0369,PSG_020664 - Draft Guidance on Cabergoline,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:45:11Z,,1,0,09000064b90ae57e
FDA-2007-D-0369-2355,FDA,FDA-2007-D-0369,PSG_218820 - Draft Guidance on Crinecerfont,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:46:59Z,,1,0,09000064b90ae58a
FDA-2007-D-0369-2346,FDA,FDA-2007-D-0369,PSG_020929 - Draft Guidance on Budesonide,Other,Guidance,2025-12-05T05:00:00Z,2025,12,2025-12-05T05:00:00Z,2026-02-04T04:59:59Z,2025-12-05T20:44:46Z,,1,0,09000064b90ae57a
FDA-2007-D-0369-2337,FDA,FDA-2007-D-0369,Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,Notice,Notice of Availability,2025-12-05T05:00:00Z,2025,12,,,2025-12-05T19:22:56Z,2025-22131,0,0,09000064b90b00b7
FDA-2007-D-0369-2297,FDA,FDA-2007-D-0369,PSG_022383 - Draft Guidance on Indacaterol Maleate,Other,Guidance,2025-11-21T05:00:00Z,2025,11,2025-11-21T05:00:00Z,2026-01-21T04:59:59Z,2025-11-21T20:09:40Z,,1,0,09000064b908bac8
FDA-2007-D-0369-2272,FDA,FDA-2007-D-0369,PSG_021658 - Draft Guidance on Ciclesonide,Other,Guidance,2025-11-21T05:00:00Z,2025,11,2025-11-21T05:00:00Z,2026-01-21T04:59:59Z,2025-11-21T20:07:23Z,,1,0,09000064b908c9be
FDA-2007-D-0369-2281,FDA,FDA-2007-D-0369,PSG_207534 - Draft Guidance on Epinephrine,Other,Guidance,2025-11-21T05:00:00Z,2025,11,2025-11-21T05:00:00Z,2026-01-21T04:59:59Z,2025-11-21T20:08:11Z,,1,0,09000064b908baa8
FDA-2007-D-0369-2325,FDA,FDA-2007-D-0369,PSG_218010 - Draft Guidance on Travoprost,Other,Guidance,2025-11-21T05:00:00Z,2025,11,2025-11-21T05:00:00Z,2026-01-21T04:59:59Z,2025-11-21T20:12:07Z,,1,0,09000064b908ca20
FDA-2007-D-0369-2264,FDA,FDA-2007-D-0369,PSG_217424 - Draft Guidance on Berdazimer Sodium,Other,Guidance,2025-11-21T05:00:00Z,2025,11,2025-11-21T05:00:00Z,2026-01-21T04:59:59Z,2025-11-21T20:06:35Z,,1,0,09000064b908c9ae
FDA-2007-D-0369-2329,FDA,FDA-2007-D-0369,PSG_209241 - Draft Guidance on Valbenazine Tosylate,Other,Guidance,2025-11-21T05:00:00Z,2025,11,2025-11-21T05:00:00Z,2026-01-21T04:59:59Z,2025-11-21T20:12:31Z,,1,0,09000064b908ca28
FDA-2007-D-0369-2285,FDA,FDA-2007-D-0369,PSG_210589 - Draft Guidance on Fish Oil Triglycerides,Other,Guidance,2025-11-21T05:00:00Z,2025,11,2025-11-21T05:00:00Z,2026-01-21T04:59:59Z,2025-11-21T20:08:35Z,,1,0,09000064b908bab0
FDA-2007-D-0369-2301,FDA,FDA-2007-D-0369,PSG_204410 - Draft Guidance on Draft Guidance on Macitentan,Other,Guidance,2025-11-21T05:00:00Z,2025,11,2025-11-21T05:00:00Z,2026-01-21T04:59:59Z,2025-11-21T20:10:01Z,,1,0,09000064b908bad0
FDA-2007-D-0369-2276,FDA,FDA-2007-D-0369,PSG_216099 - Draft Guidance on Dasatinib,Other,Guidance,2025-11-21T05:00:00Z,2025,11,2025-11-21T05:00:00Z,2026-01-21T04:59:59Z,2025-11-21T20:07:45Z,,1,0,09000064b908ba9e
FDA-2007-D-0369-2290,FDA,FDA-2007-D-0369,PSG_210828 - Draft Guidance on Gallium GA 68 Edotreotide,Other,Guidance,2025-11-21T05:00:00Z,2025,11,2025-11-21T05:00:00Z,2026-01-21T04:59:59Z,2025-11-21T20:09:02Z,,1,0,09000064b908baba
FDA-2007-D-0369-2310,FDA,FDA-2007-D-0369,PSG_208051 - Draft Guidance on Neratinib Maleate,Other,Guidance,2025-11-21T05:00:00Z,2025,11,2025-11-21T05:00:00Z,2026-01-21T04:59:59Z,2025-11-21T20:10:48Z,,1,0,09000064b908ca02
FDA-2007-D-0369-2326,FDA,FDA-2007-D-0369,PSG_216158 - Draft Guidance on Trospium Chloride; Xanomeline Tartrate,Other,Guidance,2025-11-21T05:00:00Z,2025,11,2025-11-21T05:00:00Z,2026-01-21T04:59:59Z,2025-11-21T20:12:13Z,,1,0,09000064b908ca22
FDA-2007-D-0369-2312,FDA,FDA-2007-D-0369,PSG_204508 - Draft Guidance on Olive Oil; Soybean Oil,Other,Guidance,2025-11-21T05:00:00Z,2025,11,2025-11-21T05:00:00Z,2026-01-21T04:59:59Z,2025-11-21T20:10:58Z,,1,0,09000064b908ca06
FDA-2007-D-0369-2273,FDA,FDA-2007-D-0369,PSG_213227 - Draft Guidance on Copper CU-64 Dotatate,Other,Guidance,2025-11-21T05:00:00Z,2025,11,2025-11-21T05:00:00Z,2026-01-21T04:59:59Z,2025-11-21T20:07:28Z,,1,0,09000064b908c9c0
FDA-2007-D-0369-2304,FDA,FDA-2007-D-0369,PSG_216755 - Draft Guidance on Metronidazole,Other,Guidance,2025-11-21T05:00:00Z,2025,11,2025-11-21T05:00:00Z,2026-01-21T04:59:59Z,2025-11-21T20:10:18Z,,1,0,09000064b908c9d8